References
- Aronson JK. Meyler’s side effects of drugs (sixteenth edition). The international encyclopedia of adverse drug reactions and interactions. Dexketoprofen. Oxford (UK): Elsevier; 2016. p. 888–890. https://doi.org/10.1016/B978-0-444-53717-1.01685-1
- Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-inflamm Antiallergy Agents Med Chem. 2012;11(1):52–64. https://doi.org/10.2174/187152312803476255
- Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018 Feb;154(3):500–514. https://doi.org/10.1053/j.gastro.2017.10.049
- Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients – A systematic review and meta-analysis. Antibiotics. 2017 Oct;6(4):21. https://doi.org/10.3390/antibiotics6040021
- Caillé G, Besner JG, Lacasse Y, Vézina M. Pharmacokinetic characteristics of ketoprofen suppositories. Biopharm Drug Dispos. 1980 Apr–Jun;1(4):195–201. https://doi.org/10.1002/bdd.2510010407
- Cheng X, Huang F, Zhang K, Yuan X, Song C. Effects of nonsteroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats. Biochem Biophys Res Commun. 2018;507:420–425. https://doi.org/10.1016/j.bbrc.2018.11.054
- CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard – 10th ed. CLSI document M07-A10. Wayne (USA): Clinical and Laboratory Standards Institute; 2015.
- Elshaer SL, Shaldam MA, Shaaban MI. Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii. J Appl Microbiol. 2022 Oct; 133(4): 2182–2197. https://doi.org/10.1111/jam.15609
- EMA. Ipren, suppositories 125 mg [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2003 [cited 2023 Jun 30]. Available from http://art45-paediatric-studies-docs.ema.europa.eu/GROUP%20I/ibuprofen/ibuprofen%20573-CHC-9127-001.pdf
- Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, Sakamoto Y, Koide T, Takahashi H, Yoneda M, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011 Jul;46(7):894–905. https://doi.org/10.1007/s00535-011-0410-1
- Gajdacs M, Spengler G. The role of drug repurposing in the development of novel antimicrobial drugs: non-antibiotic pharmacological agents as quorum sensing-inhibitors. Antibiotics. 2019;8(4):270. https://doi.org/10.3390/antibiotics8040270
- Gonzalez-Canudas J, Garcia-Aguirre LJ, Medina-Nolasco A, Ruiz-Olmedo MI, Reyes LJM, Zambrano-Tapia L, Romero-Antonio Y, Molina-Pérez A, Amador-Hernández AG. Bioequivalence evaluation of two oral formulations of dexketoprofen-trometamol (solution and tablets) in healthy subjects: Results from a randomized, single-blind, crossover study. Trends Med. 2019;19:1–5. https://doi.org/10.15761/TiM.1000176
- Janssen GM, Venema JF. Ibuprofen: Plasma concentrations in man. J Int Med Res. 1985;13(1):68–73. https://doi.org/10.1177/030006058501300110
- Jiménez-Serna A, Hernandez-Sánchez H. Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota. Curr Microbiol. 2011 Mar;62(3): 1028–1033. https://doi.org/10.1007/s00284-010-9819-7
- Kerry GR, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: A review. J Food Drug Anal. 2018 Jul;26(3):927–939. https://doi.org/10.1016/j.jfda.2018.01.002
- Klopper KB, Deane SM, Dicks LMT. Aciduric strains of Lactobacillus reuteri and Lactobacillus rhamnosus, isolated from human feces, have strong adhesion and aggregation properties. Probiotics Antimicrob Proteins. 2018 Mar;10(1):89–97. https://doi.org/10.1007/s12602-017-9307-5
- Kmiec N, Welnicka-Jaskiewicz M, Jassem J. [Nonsteroidal anti-inflammatory drugs in the prevention and treatment of colorectal cancer] (in Polish). J Oncol. 2014;64(2):175–179. https://doi.org/10.5603/NJO.2014.0024
- Kruszewska H, Zareba T, Kociszewska A, Tyski S. Activity of selected non-antibiotic medicinal preparations against standard microorganisms including bacterial probiotic strains. Acta Pol Pharm Drug Res. 2021;78(2):179–185. https://doi.org/10.32383/appdr/136439
- Kruszewska H, Zaruba T, Tyski S. Examination of antimicrobial activity of selected non-antibiotic medicinal preparations. Acta Pol Pharm Drug Res. 2012;69(6):1368–1371.
- Lagadinou M, Onisor MO, Rigas A, Musetescu DV, Gkentzi D, Assimakopoulos SF, Panos G, Marangos M. Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance. Antibiotics. 2020 Mar;9(3):107. https://doi.org/10.3390/antibiotics9030107
- Laudy AE, Kulinska E, Tyski S. The impact of efflux pump inhibitors on the activity of selected non-antibiotic medicinal products against Gram-negative bacteria. Molecules. 2017 Jan;22(1):114. https://doi.org/10.3390/molecules22010114
- Laudy AE, Mrowka A, Krajewska J, Tyski S. The influence of efflux pump inhibitors on the activity of non-antibiotics NSAIDS against Gram-negative rods. PLoS One. 2016 Jan;11(1):e0147131. https://doi.org/10.1371/journal.pone.0147131
- Laudy AE. Non-antibiotics, efflux pumps and drug resistance of Gram-negative rods. Pol J Microbiol. 2018 Jun;67(2):129–135. https://doi.org/10.21307/pjm-2018-017
- Lázár B, László SB, Hutka B, Toth AS, Mohammadzadeh A, Berekmeri E, Ägg B, Balogh M, Sajtos V, Kiraly K, et al. A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine. Biochem Pharmacol. 2021 Aug;190:114590. https://doi.org/10.1016/j.bcp.2021.114590
- Leäo C, Borges A, Simões M. NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics. 2020 Sep;9(9):591. https://doi.org/10.3390/antibiotics9090591
- Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, Fitz Gerald GA. Bidirectional interactions between indomethacin and the murine intestinal microbiota. elife. 2015 Dec;4:e08973. https://doi.org/10.7554/eLife.08973
- Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29;555(7698):623–628. https://doi.org/10.1038/nature25979
- Markowiak-Kopec P, Slizewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020 Apr;12(4):1107. https://doi.org/10.3390/nu12041107
- Maseda D, Ricciotti E. NSAID-gut microbiota interactions. Front Pharmacol. 2020 Aug;11:1153. https://doi.org/10.3389/fphar.2020.01153
- Montrose DC, Zhou XK, McNally EM, Sue E, Yantiss RK, Gross SS, Leve ND, Karoly ED, Suen CS, Ling L, et al. Celecoxib alters the intestinal microbiota and metabolome in association with reducing polyp burden. Cancer Prev Res (Phila). 2016 Sep;9(9):721–731. https://doi.org/10.1158/1940-6207.CAPR-16-0095
- Nadatani Y, Watanabe T, Suda W, Nakata A, Matsumoto Y, Kosaka S, Higashimori A, Otani K, Hosomi S, Tanakaet F, et al. Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii. Sci Rep. 2019 Nov; 9(1):17490. https://doi.org/10.1038/s41598-019-53559-7
- Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T. Pharmacokinetics and pharmacodynamicsof acetylsalicylic acid after intravenous and oral administration to healthy volunteers. Clin Pharmacol. 2014 Mar;6:51–59. https://doi.org/10.2147/CPAA.S47895
- Nair BM, Cheung KJ Jr, Griffith A, Burns JL. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest. 2004 Feb;113(3):464–473. https://doi.org/10.1172/JCI19710
- Novartis Pharmaceuticals UK Ltd. Voltarol 12.5 mg Suppositories summary of product characteristics [Internet]. Electronic Medicines Compendium; 2023 [cited 2023 Jun 30]. Available from https://www.medicines.org.uk/emc/product/1044/smpc
- Phillips WJ, Currier BL. Analgesic pharmacology: II. Specific analgesics. J Am Acad Orthop Surg. 2004 Jul-Aug;12(4):221–233. https://doi.org/10.5435/00124635-200407000-00003
- Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm. 2002 Jul;241(1):165–172. https://doi.org/10.1016/s0378-5173(02)00230-2
- Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M. Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. Clin Exp Rheumatol. 2013 Sep–Oct; 31(5):731–738.
- Scaroni C, Mazzoni PL, D’Amico E, Benvenuti C, Hind ID. Pharmacokinetics of oral and rectal flurbiprofen in children. Eur J Clin Pharmacol. 1984;27(3):367–369. https://doi.org/10.1007/BF00542178 Standards Institute; 2015.
- Suzuki T, Masui A, Nakamura J, Shiozawa H, Aoki J, Nakae H, Tsuda S, Imai J, Hideki O, Matsushima M, et al. Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: A prospective, randomized, double-blind, placebo-controlled trial. Digestion. 2017;95(1):49–54. https://doi.org/10.1159/000452361
- Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E, Bercik P, Surette MG, Aucouturier A, Langella P, et al. NSAID enteropathy and bacteria: A complicated relationship. J Gastroenterol. 2015 Apr;50(4):387–393. https://doi.org/10.1007/s00535-014-1032-1
- Tyski S. Non-antibiotics – drugs with additional antimicrobial activity. Acta Pol Pharm Drug Res. 2003;60(5):401–404.
- Valentovic M. Flurbiprofen. In: Enna SJ and Bylun DB, editors. xPharm: The comprehensive pharmacology reference. New York (USA): Elsevier; 2007. p. 1–6. https://doi.org/10.1016/B978-008055232-3.61777-5
- Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, et al. Gut microbiota in NSAID enteropathy: New insights from inside. Front Cell Infect Microbiol. 2021 Jul;11:679396. https://doi.org/10.3389/fcimb.2021.679396
- Watanabe T, Nishio H, Tanigawa T, Yamagami H, Okazaki H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Asahara T, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G506-G513. https://doi.org/10.1152/ajpgi.90553.2008
- Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol. 1979;16(6):405–410. https://doi.org/10.1007/BF00568201
- Yilmaz B, Erdem AF. Determination of flurbiprofen in human plasma by high-performance liquid chromatography. J Chromatogr Sci. 2015 Oct;53(9):1443–1448. https://doi.org/10.1093/chromsci/bmv032
- Yu T, Lao X, Zheng H. Influencing COX-2 activity by COX related pathways in inflammation and cancer. Mini Rev Med Chem. 2016; 16(15):1230–1243. https://doi.org/10.2174/1389557516666160505115743
- Zádori ZS, Kiraly K, Al-Khrasani M, Gyires K. Interactions between NSAIDs, opioids and the gut microbiota – Future perspectives in the management of inflammation and pain. Pharmacol Ther. 2023 Jan;241:108327. https://doi.org/10.1016/j.pharmthera.2022.108327
- Zawistowska-Rojek A, Tyski S. How to improve health with biological agents – Narrative review. Nutrients. 2022 Apr;14(9):1700. https://doi.org/10.3390/nu14091700
- Zimmermann P, Curtis N. Antimicrobial effects of antipyretics. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02268-16. https://doi.org/10.1128/AAC.02268-16